G
Guido Lupinacci
Publications - 4
Citations - 494
Guido Lupinacci is an academic researcher. The author has contributed to research in topics: Ulcerative colitis & Inflammatory bowel disease. The author has an hindex of 3, co-authored 4 publications receiving 430 citations.
Papers
More filters
Journal ArticleDOI
East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort
Johan Burisch,Niels C Pedersen,Silvija Čuković-Čavka,Marko Brinar,I. Kaimakliotis,Dana Duricova,Olga Shonová,Ida Vind,Søren Avnstrøm,Niels Thorsgaard,Vibeke Andersen,Simon Laiggard Krabbe,Jens Frederik Dahlerup,Riina Salupere,K R Nielsen,J. Olsen,Pekka Manninen,Pekka Collin,E.V. Tsianos,Konstantinos Katsanos,K. Ladefoged,Laszlo Lakatos,Einar Björnsson,G. Ragnarsson,Y. Bailey,Shmuel Odes,Doron Schwartz,Matteo Martinato,Guido Lupinacci,Monica Milla,A. De Padova,Renata D'Incà,M Beltrami,Limas Kupčinskas,Gediminas Kiudelis,Svetlana Turcan,O Tighineanu,I Mihu,Fernando Magro,Fernando Magro,L. Barros,Adrian Goldis,Daniela Lazăr,Elena Belousova,Inna Nikulina,Veronica Moset Hernandez,D. Martinez-Ares,Sven Almer,Yaroslava Zhulina,Jonas Halfvarson,Naila Arebi,Shaji Sebastian,Peter L. Lakatos,Ebbe Langholz,Pia Munkholm +54 more
TL;DR: Whether an East–West gradient in the incidence of inflammatory bowel disease in Europe exists is investigated to find out whether international guidelines for diagnosis and initial treatment are not being followed uniformly by physicians.
Journal ArticleDOI
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
Z. Vegh,Z. Vegh,Johan Burisch,Niels C Pedersen,I. Kaimakliotis,Dana Duricova,Martin Bortlik,Søren Avnstrøm,K. Kofod Vinding,J. Olsen,K R Nielsen,K.H. Katsanos,E.V. Tsianos,Laszlo Lakatos,Doron Schwartz,Shmuel Odes,Guido Lupinacci,A. De Padova,Laimas Virginijus Jonaitis,Limas Kupčinskas,Svetlana Turcan,O Tighineanu,I Mihu,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Alberto Fernandez,Vicent Hernandez,O Niewiadomski,Sally Bell,Ebbe Langholz,Pia Munkholm,Peter L. Lakatos,EpiCom-group +34 more
TL;DR: Incidence rates, disease phenotype and initial treatment characteristics in the 2011 ECCO-EpiCom cohort were not significantly different from that reported in the 2010 cohort.
Journal ArticleDOI
Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study
Johan Burisch,Hillel Vardi,Natalia Pedersen,Marko Brinar,S. Cukovic-Cavka,I. Kaimakliotis,Dana Duricova,Martin Bortlik,Olga Shonová,Ida Vind,Søren Avnstrøm,Niels Thorsgaard,Susanne Krabbe,Vibeke Andersen,Jens Frederik Dahlerup,Jens Kjeldsen,Riina Salupere,Jónger Olsen,K R Nielsen,Pia Manninen,Pekka Collin,Konstantinnos H. Katsanos,Epameinondas V. Tsianos,K. Ladefoged,Laszlo Lakatos,Y. Bailey,Colm A. OʼMorain,Doron Schwartz,Guido Lupinacci,Angelo De Padova,Laimas Virginijus Jonaitis,Limas Kupčinskas,Svetlana Turcan,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Inna Nikulina,Elena Belousova,Alberto Fernandez,Juan R. Pineda,Sven Almer,Jonas Halfvarson,Her-Hsin Tsai,Shaji Sebastian,Michael Friger,Dan Greenberg,Peter L. Lakatos,Ebbe Langholz,Selwyn Odes,Pia Munkholm +50 more
TL;DR: In this population-based unselected cohort of unselected inflammatory bowel disease patients, costs during the first year of disease were mainly incurred by investigative procedures and surgeries, however, biologicals accounted for >15% of costs.